Ex‐vivo drug testing predicts chemosensitivity in acute myeloid leukemia-Reference-Cited by-同舟云学术

Ex‐vivo drug testing predicts chemosensitivity in acute myeloid leukemia

Published:2020-04-15 Issue:5 Volume:107 Page:859-870
ISSN:0741-5400
Container-title:Journal of Leukocyte Biology
language:en
Short-container-title:J Leukoc Biol

Author:

Lin Lihui¹,Tong Yin²,Straube Jasmin³,Zhao Jinyan¹,Gao Yanting¹,Bai Ping¹,Li Jia¹,Wang Juan¹,Wang Hongling¹,Wang Xiaorui¹,Huang Sheng¹,Xu Wen¹,Song Xianmin²,Li Li¹⁴

Affiliation:

1. Department of Laboratory Medicine Shanghai General Hospital Shanghai Jiao Tong University School of Medicine Shanghai China

2. Department of Hematology Shanghai General Hospital Shanghai Jiao Tong University School of Medicine Shanghai China

3. Gordon and Jessie Gilmour Leukaemia Research Laboratory QIMR Berghofer Medical Research Institute Brisbane Australia

4. Department of Laboratory Medicine Shanghai General Hospital Baoshan Branch Shanghai Jiao Tong University School of Medicine Shanghai China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cell Biology,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/JLB.5A0220-676RR

Reference32 articles.

1. Genomic Classification and Prognosis in Acute Myeloid Leukemia

2. Drug Repurposing for the Treatment of Acute Myeloid Leukemia

3. Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

4. Institute NC.Cancer stat facts: leukemia‐acute myeloid leukemia (AML).2017.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical forecasting of acute myeloid leukemia using ex vivo drug-sensitivity profiling;Cell Reports Methods;2023-12

2. Ex vivo discovery of synergistic drug combinations for hematologic malignancies;SLAS Discovery;2023-12

3. Therapeutic strategies for non-small cell lung cancer: Experimental models and emerging biomarkers to monitor drug efficacies;Pharmacology & Therapeutics;2023-02

4. Ex Vivo Drug Sensitivity Correlates with Clinical Response and Supports Personalized Therapy in Pediatric AML;Cancers;2022-12-18

5. Role of Biomarkers in the Management of Acute Myeloid Leukemia;International Journal of Molecular Sciences;2022-11-22